AUG 7, 2026 · PHASE 2 TRIAL
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
ClinicalTrials.gov
This is a Phase 2 interventional trial registration with no results reported; the study is actively recruiting and has not yet yielded efficacy or safety data.
Reported
Planned enrollment332
PhasePhase 2
Primary outcome measureResponse rate at 6 and 12 weeks after cell…